Painful neuropathies

Current Opinion in Neurology

Volumn 11, Issue 5, 1998, Pages 515-521

  Koltzenburg, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

CENTRAL NERVOUS SYSTEM; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; HUMAN; HYPOALGESIA; MUSCLE SPINDLE AFFERENT NERVE; NERVE LESION; NEUROPATHY; NOCICEPTION; PAIN; PERIPHERAL NERVE; REVIEW; SENSORY NERVE CELL;

HUMANS; NERVOUS SYSTEM DISEASES; PAIN; PAIN MEASUREMENT;

EID: 0031782255     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199810000-00014     Document Type: Review

References (103)

1. Merskey H, Bogduk M. Classification of chronic pain. 2nd edn. Seattle: IASP Press; 1994.
2. Koltzenburg M. Afferent mechanisms mediating pain and hyperalgesia in neuralgia. In: Reflex sympathetic dystrophy: a reappraisal. Jänig W, Stanton-Hicks M (editors). Seattle: IASP Press; 1996. pp 123-150.
3. Zaslansky R, Yarnitsky D. Clinical applications of quantitative sensory testing (QST). J Neurol Sci 1988; 153:215-238.
4. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: normative data and repeatability. Pain 1995; 60:329-332.
5. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Multiple session experimental pain measurement. Pain 1996; 67:327-333.
6. Yarnitsky D, Sprecher E, Tamir A, Zaslansky R, Hemli JA. Variance of sensory threshold measurements: discrimination of feigners from trustworthy performers. J Neurol Sci 1994; 125:186-189.
7. Price DD, Long S, Huitt C. Sensory testing ot pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992; 49:163-173.
8. Koltzenburg M, Torebjörk HE, Wahren LK. Nociceptor modulated central plasticity causes mechanical hyperalgesia in chronic neuropathic and acute chemogenic pain. Brain 1994; 117:579-591.
9. Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997; 48:708-711. This study used punch biopsies of the skin to quantify the density of the epidermal innervation that is derived from unmyelinated afferents. It is shown that there is a reduction in the innervation density in painful neuropathies compared with normal control individuals.
10. ••], this paper clearly describes the diagnostic value of studying the cutaneous innervation in neuropathy.
11. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45:1848-1855.
12. Koltzenburg M. Afferent mechanisms mediating pain and hyperalgesia in Neuralgia. In: Reflex sympathetic dystrophy: a reappraisal. Jäng W, Stanton-Hicks M (editors). Seattle: IASP Press; 1996. pp 123-150.
13. Fields HL, Rowbotham MC, Devor M. Excitability blockers: anticonvul-sants and low concentration local anesthetics in the treatment of chronic pain. In: The pharmacology of pain. Dickenson A, Besson J-M (editors). Berlin: Springer Verlag; 1997. pp 93-116. A timely review in the Handbook of Pharmacology that summarises the current knowledge about the effects of anticonvulsants and local anaesthetics in the management of pain.
14. Arnér S, Lindblom U, Meyerson BA, Molander C. Prolonged relief of neuralgia after regional anesthetic blocks. A call for further experimental and systematic clinical studies. Pain 1990; 43:287-297.
15. Rowbotham MC, Fields HL. Topical lidocaine reduces pain in postherpetic neuralgia. Pain 1989; 38:297-301.
16. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing, maintained dynamically by peripheral input. Pain 1992; 51:175-194.
17. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37:246-253.
18. Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988; 32:89-94.
19. Ochoa JL, Yarnitsky D. Mechanical hyperalgesias in nueropathic pain patients: dynamic and static subtypes. Ann Neurol 1993; 33:465-472.
20. Torebjörk E, Wahren LK, Wallin G, Hallin R, Koltzenburg M. Noradrenaline-evoked pain in neuralgia. Pain 1995; 63:11-20.
21. Price DD, Bennett GJ, Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989; 36:273-288.
22. Torebjörk E. Clinical and neurophysiological observations relating to pathophysiological mechanisms in reflex sympathetic dystrophy. In: Reflex sympathetic dystrophy. Edited by Stanton-Hicks M, Jänig W, Boas RA (editors). Boston: Kluwer Academic Publishers; 1990. pp 71-80.
23. Fruhstorfer H, Lindblom U. Sensibility abnormalities in neuralgic patients studied by thermal and tactile pulse stimulation. In: Somatosensory mechanisms. von Euler U, Franzén O, Lindblom U, Ottoson D (editors). London: Macmillan Press; 1984. pp 353-361.
24. Koltzenburg M, Torebjörk HE, Wahren LK. Nociceptor modulated central plasticity causes mechanical hyperalgesia in chronic neuropathic and acute chemogenic pain. Brain 1994; 117:579-591.
25. Koltzenburg M, Lundberg LER, Torebjörk He. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992; 51:207-219.
26. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing, maintained dynamically by peripheral input. Pain 1992; 51:175-194.
27. Treede R-D, Davis KD, Campbell JN, Raja SN. The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. Brain 1992; 115:607-621.
28. Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 1996; 119:347-354.
29. Devor M, Jänig W. Activation of myelinated afferents ending in a neuroma by stimulation of the sympathetic supply in the rat. Neurosci Lett 1981; 24:43-47.
30. Jànig W. Pathophysiology of nerve following mechanical injury. In: Proceedings of the Vth World Congress on Pain. Dubner R. Gebhart GF, Bond MR (editors). Amsterdam: Elsevier; 1988. pp. 89-108.
31. Devor M. Pathophysiology of injured nerve. In: Textbook of pain 3 edn. Wall PD, Melzack R (editors). Edinburgh: Churchill Livingstone; 1994. pp 79-100.
32. Koltzenburg M, Kees S, Budweiser S, Ochs G, Toyka KV. The properties of unmyelinated afferents change in a chronic constriction neuropathy. In: Proceedings of the Vllth World Congress on Pain. Gebhart GF, Hammond DL, Jensen TS (editors). Seattle: IASP Press; 1994. pp 511-522.
33. Devor M, Lomazov P, Matzner O. Sodium channel accumulation in injured axons as a substrate for neuropathic pain. In: Touch, temperature, and pain in health and disease: mechanisms and assessments. Boivie J, Hansson P, Lindblom U (editors). Seattle: IASP Press; 1994. pp 207-230.
34. Waxman SG, Kocsis JD, Black JA. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 1994; 72:466-470.
35. Cummins TR, Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 1997; 17:3503-3514. A detailed electrophysiological study using patch clamp technique demonstrating the changes in different sodium currents following axotomy that could lead to hyperexcitability in sensory neurons.
36. Akopian AN, Sivilotti L, Wood JN. A tetradotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996; 379:257-262.
37. Dibhajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci USA 1998; 95:8963-8968. Identification and sequencing of a novel TTX-insensitive sodium channel in sensory neurons. It is generally thought that only one type of TTX-resistant sodium channels can be found in dorsal root ganglion cells. This is the first convincing description that there may be multiple TTX-resistant channels, and like the previously known SNS-sodium channel [36] it was shown that its mRNA is downregulated after axotomy. This observation has obvious implications for the development of novel analgesic drugs that target the sodium channel.
38. Novakovic SD, Tzoumaka E, McGivern JG, Haraguchi M. Sangameswaran L, Gogas KR, et al. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 1998; 18:2174-2187. Researchers show that there is a redistribution of the classical tetrodotoxin-insensitive sodium channel SNS (also known as PN3) in sensory neurons after axotomy and that the downregulation of mRNA stands in striking contrast to the change of the channel protein in different locations of the damaged neuron. The paper argues that redistribution of ion channels is an important aspect of the generation of neuropathic pain. Yet unpublished reports from the same group show that this behaviour can contrast with the regulation and distribution of other sodium channels that are also found in sensory neurons.
39. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992; 48:261-268.
40. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997; 324:153-160.
41. Jett MF, McGuirk J, Waligora D, Hunter JC. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain 1997; 69:161-169.
42. •], together with, shows that compounds that interfere with sodium conductances in damaged sensory neurons can reduce the ectopic activity of axotomised sensory neurons.
43. •].
44. Kajander KC, Wakisaka S, Bennett GJ. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett 1992; 138:225-228.
45. Michaelis M, Vogel C, Blenk KH, Jänig W. Algesics excite axotomised afferent nerve fibres within the first hours following nerve transection in rats. Pain 1997; 72:347-354.
46. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997; 81:255-262.
47. Koltzenburg M. The sympathetic nervous system with pain. In: The pharmacology on pain. Dickenson A, Besson J-M (editors). Berlin: Springer Verlag; 1997. pp 61-91. A review in the Handbook of Pharmacology that summarises the current concepts of sympathetically-maintained pain.
48. Zhang JM, Song XJ, Lamotte RH. An in vitro study of ecotopic discharge generation and adrenergic sensitivity in the intact, nerve-injured rat dorsal root ganglion. Pain 1997; 72:51-57.
49. Xie Y, Zhang J, Petersen M, Lamotte RH. Functional changes in dorsal root ganglion cells after chronic nerve constriction in the rat. J Neurophysiol 1995; 73:1811-1820.
50. Chen Y, Michaelis M, Jänig W, Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 1996; 76:3721-3730.
51. Michaelis, M, Devor M, Janig W. Sympathetic modulation of activity in rat dorsal root ganglion neurons changes over time following peripheral nerve injury. J Neurophysiol 1996; 76:753-763.
52. Petersen M, Zhang JM, Lamotte RH. Abnormal spontaneous activity and responses to norepinephrine in dissociated dorsal root ganglion cells after chronic nerve constriction. Pain 1996; 67:391-397.
53. 2+ channels in axotomized rat sensory neurons. J Neurosci 1997; 17:1633-1641.
54. Lisney SJ. Regeneration of unmyelinated axons after injury of mammalian peripheral nerve. Q J Exp Physiol 1989; 74:757-784.
55. Devor M, Wall PD. Cross-excitation in dorsal root ganglia of nerve-injured and intact rats. J Neurophysiol 1990; 64:1733-1746.
56. Lisney SJ, Devor M. After discharge and interactions among fibers in damaged peripheral nerve in the rat. Brain Res 1987; 415:122-136.
57. Utzchneider D, Kocsis J, Devor M. Mutual excitation among dorsal root ganglion neurons in the rat. Neurosci Lett 1992; 146:53-56.
58. Amir R, Devor M, Chemically mediated cross-excitation in rat dorsal root ganglia. J Neurosci 1996; 16:4733-4741.
59. Koschorke GM, Meyer RA, Tillman DB, Campbell JN. Ectopic excitability of injured nerves in monkey: entrained responses to vibratory stimuli. J Neurophysiol 1991; 65:693-701.
60. Michaelis M, Blenk KH, Jänig W, Vogel C. Development of spontaneous activity and mechanosensitivity in axotomized afferent nerve fibers during the first hours after nerve transection in rats. J Neurophysiol 1995; 74:1020-1027.
61. McMahon SB, Lewin GR, Wall PD. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993; 3:602-610.
62. MA QP, Woolf CJ. Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain 1996; 67:97-106.
63. Dickenson A. Mechanisms of central hypersensitivity: excitatory amino acid mechanisms and their control. In: The pharmacology of pain. Besson J-M (editors). Berlin: Springer Verlag; 1997. pp 167-210. A review in the Handbook of Pharmacology that summarises the current knowledge about the role of excitatory amino acids in synaptic transmission in the dorsal horn of the spinal cord.
64. Birch PJ. Tachykinins: central and peripheral effects. In: The pharmacology of pain. Dickenson A, Besson J-M (editors). Berlin: Springer Verlag; 1998. pp 135-165. A review in the Handbook of Pharmacology that summarises the current knowledge about the role of substance P and other tachykinins in synaptic transmission in the dorsal horn of the spinal cord.
65. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356:521-523.
66. Yu XM, Askalan R, Keil GJ, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 1997; 275:674-678.
67. Suen PC, Wu K, Levine ES, Mount HT, Xu JL, Lin SY, Black IB. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1. Proc Natl Acad Sci USA 1997; 94:8191-8195.
68. Woolf CJ, Mannion RJ, Neumann S. Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology. Neuron 1998; 20:1063-1066. A timely review that summarises the new insights gained from the study of mice with null mutations of substance P precursors or its cognate receptor NK1.
69. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci Lett 1995; 198:75-78.
70. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res 1995; 677:257-267.
71. McQuay H, Moore A. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998. A thoughtful book reviewing the methodology of evidence-based medicine and its application to systematic evaluation of pain therapy. It is bound to become a classic.
72. Malmberg AB, Chen C, Tonegawa S, Basbaum AI. Preserved acute pain and reduced neuropathic pain in mice lacking PKC gamma. Science 1997; 278:279-283. This study demonstrated that PKCγ is localised to a small subset of sensory neurons in the substantia gelatinosa of the superficial dorsal horn of the spinal cord which receives synaptic input from small diameter nonpeptidergic sensory neurons with nociceptive function. Intriguingly, animals lacking this intracellular enzyme display a blunted pain response in models of neuropathic pain while retaining a normal sensitivity in models of noninflammatory pain.
73. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44:105-117.
74. Sugimoto T, Bennett GJ, Kajander KC. Strychnine-enhanced transsynaptic degeneration of dorsal horn neurons in rats with an experimental painful peripheral neuropathy. Neurosci Lett 1989; 98:139-143.
75. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine. Pain 1990; 42:205-213.
76. Mao JR, Price DD, Zhu JP, Lu J, Mayer DJ. The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997; 72:355-366.
77. Mannion RJ, Doubell TP, Gill H, Woolf CJ. Deafferentation is insufficient to induce sprouting of A-fibre central terminals in the rat dorsal horn. J Comp Neurol 1998; 393:135-144.
78. Woolf CJ, Shortland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 355:75-78.
79. Woolf CJ, Doubell TP. The pathophysiology of chronic pain-increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol 1994; 4:525-534.
80. Doubell TP, Mannion RJ, Woolf CJ. Intact sciatic myelinated primary afferent terminals collaterally sprout in the adult rat dorsal horn following section of a neighbouring peripheral nerve. J Comp Neurol 1997; 380:95-104.
81. Manninon RJ, Doubell TP, Coggeshall RE, Woolf CJ. Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J Neurosci 1996; 16:5189-5195.
82. Snider WD, McMahon SB. Tackling pain at source: new ideas about nociceptors. Neuron 1998; 20:629-632. A timely review that summarises the emerging dichotomy of nociceptors into peptidergic and nonpeptidergic based on different growth factor requirements.
83. Bennett DLH, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, et al. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 1998; 18:3059-3072. GDNF and NGF are capable of preventing the abnormal growth of Aß-fibres into the marginal layer and substantia gelatinosa of the spinal cord after axotomy. If this structural change in Aß-fibres causes abnormal sensations in painful neuropathies it raises the possibility that neurotrophic factors have a role for the prevention of the development of 'abnormal pain circuits' in the dorsal horn of the spinal cord.
84. Bennett DL, French J, Priestley JV, McMahon SB. NGF but not NT-3 or BDNF prevents the A fiber sprouting into lamina II of the spinal cord that occurs following axotomy. Mol Cell Neurosci 1996; 8:211-220.
85. Baron R, Saguer M. Postherpetic neuralgia: are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain 1993; 116:1477-1496.
86. Treede R-D, Davis KD, Campbell JN, Raja SN. The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. Brain 1992; 115:607-621.
87. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68:217-227.
88. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone; 1997. The red bible of evidence-based medicine.
89. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-720.
90. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995; 311:1047-1052.
91. Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitsky D. Lamotrigine in the treatment of painful diabetic neuropathy. Eur J Neurol 1998; 5:167-173.
92. Rosenberg JM, Harrell C, Ristic H, Werner RA, De Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain 1997; 13:251-255.
93. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996; 12:56-58.
94. Felsby S, Nielsen J, Arendt NL, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996; 64:283-291.
95. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48:1212-1218.
96. Eide PK, Jorum E, Stubhaug A, Bremnes, J. Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58:347-354.
97. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt NL, Jensen TS. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996; 67:69-77.
98. Pud D, Eisenberg E, Spitzer A, Adler R, Fried G, Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998; 75:349-354.
99. Max MB, Byas SM, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995; 18:360-368.
100. Arnér S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33:11-23.
101. McQuay HJ. Opioid use in chronic pain. Acta Anaesthesiol Scand 1997; 41:175-183.
102. Rowbotham MC, Reisner Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41:1024-1028.
103. Dellemijn PL, Vanneste JA. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997; 349:753-758.